CCT4 exhibited diverse genomic alterations, with the highest alteration rates observed in mature B-cell neoplasm, endometrial cancer, and NSCLC, primarily driven by gene amplification and mutations (Figure 6A). The gene discussed is CCT4; the disease is endometrial cancer.